Salvia divinorum Epling & Játiva (Maria Pastora) e Salvinorina A: crescente uso recreacional e potencial de abuso Salvia divinorum Epling & Játiva ("ska María Pastora") and Salvinorin A: increasing recreational use and abuse potential
Revista Brasileira de Plantas Medicinais September 2, 2013 DOI: 10.1590/s1516-05722010000300014 via DOAJ
Summary
AI-generated from the abstractSalvia divinorum, used for centuries by the Mazateca culture, has become popular as a recreational drug. Its active compound, Salvinorin A, is a kappa opioid receptor agonist with psychotropic effects. Use has increased in Europe and North America, yet no concrete evidence of abuse exists. This review examines the plant's abuse potential and its growing recreational use, despite being a legally permitted hallucinogen easily purchased in many countries.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Salvia divinorum |
| Keywords | Salvinorina a Potencial de abuso Uso recreacional |
| Citations | 3 |
| Key finding | No concrete evidence of abuse of Salvia divinorum exists, despite its increasing recreational use. |
Abstract
A planta Salvia divinorum Epling & Játiva (SDI), da família Lamiaceae, tem sido usada por séculos pela cultura mazateca e vem ganhando popularidade como droga recreacional nos últimos anos. Seu princípio ativo - Salvinorina A (SA) - é agonista dos receptores opióides kappa, com potencial psicotrópico. A utilização da planta vem crescendo na Europa e na América do Norte, apesar de ainda não existirem provas concretas sobre abuso. A presente revisão da literatura contemporânea aborda as evidências sobre o potencial de abuso de SDI, bem como o crescente uso recreacional, ainda que seja alucinógeno permitido legalmente e de fácil compra em muitos países.The plant Salvia divinorum Epling & Játiva (SDI), of the Lamiaceae family, has been used for centuries by the Mazateca culture and has gained popularity as a recreational drug in the last years. Its active principle, Salvinorin A (SA), is a potentially psychotropic agonist of the kappa opioid receptors. The use of SDI has increased in Europe and North America, although there are no concrete proofs about abuse. The present review discusses current evidence on potential SDI abuse, as well as its increasing recreational use, although it is considered a legalized hallucinogen easily acquired in many countries.